Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
| Epinephrine | 0.2 mg/kg IV or IT |
| Furosemide | 1-4 mg/kg IM |
| Hetastarch | 20 ml/kg IV |
| Lactated Ringer's solution | 10-20 ml/kg/hr |
| Lidocaine | 1-2 mg/kg IV |